Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India.

Mishra, Varsha; Jain, Sandeep; Anand, Vaneet; Malhotra, Payal; Tejwani, Narender; Kapoor, Gauri

Mishra, Varsha; Jain, Sandeep; Anand, Vaneet; Malhotra, Payal; Tejwani, Narender; Kapoor, Gauri.

Afiliação

Mishra V; Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Jain S; Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Anand V; Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Malhotra P; Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Tejwani N; Department of Pathology, Pediatric Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.
Kapoor G; Department of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute, New Delhi, India.

Pediatr Hematol Oncol ; 40(6): 517-528, 2023.

Article em En | MEDLINE | ID: mdl-36930957

Assuntos

Leucemia-Linfoma Linfoblástico de Células Precursoras; Criança; Adolescente; Humanos; Intervalo Livre de Doença; Neoplasia Residual; Estudos Retrospectivos; Prognóstico

Palavras-chave

Acute lymphoblastic leukemia; BFM-95; children; minimal residual disease; relapse

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google